BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Manganis CD, Chapman RW, Culver EL. Review of primary sclerosing cholangitis with increased IgG4 levels. World J Gastroenterol 2020; 26(23): 3126-3144 [PMID: 32684731 DOI: 10.3748/wjg.v26.i23.3126]
URL: https://www.wjgnet.com/1007-9327/full/v26/i23/3126.htm
Number Citing Articles
1
Neil C. Khoury, John W. Birk. A Review of IgG4-related Sclerosing Cholangitis (IgG4-SC)Journal of Clinical Gastroenterology 2024;  doi: 10.1097/MCG.0000000000001984
2
Martin Cornillet, Christina Villard, Fredrik Rorsman, Antonio Molinaro, Emma Nilsson, Stergios Kechagias, Erik von Seth, Annika Bergquist. The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM)eClinicalMedicine 2024; 70: 102526 doi: 10.1016/j.eclinm.2024.102526
3
M. Álvarez García, J.C. Álvarez Torices, M.J. Díez Liébana, M.R. de la Fuente Olmos. Thoracoabdominal manifestations of immunoglobulin G4-related diseaseRadiología (English Edition) 2023; 65(2): 165 doi: 10.1016/j.rxeng.2022.06.005
4
Mazen Abdalla Rasheed, Vinícius Remus Ballotin, Lucas Goldmann Bigarella, Jonathan Soldera. Post-COVID-19 cholangiopathy: Systematic reviewWorld Journal of Methodology 2023; 13(4): 296-322 doi: 10.5662/wjm.v13.i4.296
5
Sayan Malakar, Piyush Mishra, Radha Paturu, Ritu Verma, Uday C. Ghoshal. Primary sclerosing cholangitis with high immunoglobulin-G4Journal of Hepatology 2024; 80(4): e168 doi: 10.1016/j.jhep.2023.09.026
6
Cyriel Y. Ponsioen, David N. Assis, Kirsten M. Boberg, Christopher L. Bowlus, Mark Deneau, Douglas Thorburn, Lars Aabakken, Martti Färkkilä, Bret Petersen, Christian Rupp, Stefan G. Hübscher. Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus ProcessGastroenterology 2021; 161(6): 1764 doi: 10.1053/j.gastro.2021.07.046
7
Adrian C. Bateman, Emma L. Culver. Challenges and pitfalls in the diagnosis of IgG4-related diseaseSeminars in Diagnostic Pathology 2024; 41(2): 45 doi: 10.1053/j.semdp.2023.11.005
8
Jixuan Wang, Zhiwen Sun, Jingri Xie, Wanli Ji, Yang Cui, Zongxiong Ai, Guoying Liang. Inflammasome and pyroptosis in autoimmune liver diseasesFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1150879
9
Ivan Isaia, Giuseppe Natoli, Michele Colaci, Benedetta Stancanelli, Lorenzo Malatino. Sclerosing cholangitis may mimic radiological pattern of cholangiocarcinoma: Differential diagnosis and review of literatureThe American Journal of the Medical Sciences 2022; 364(3): 359 doi: 10.1016/j.amjms.2022.04.016
10
Aalam Sohal, Sanya Kayani, Kris V. Kowdley. Primary Sclerosing CholangitisClinics in Liver Disease 2024; 28(1): 129 doi: 10.1016/j.cld.2023.07.005
11
Ruchika Goel, Chundamannil Eapen Eapen. Recognizing Dysfunctional Innate and Adaptive Immune Responses Contributing to Liver Damage in Patients With CirrhosisJournal of Clinical and Experimental Hepatology 2022; 12(3): 993 doi: 10.1016/j.jceh.2021.10.001
12
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disordersWorld Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
13
Florian Fronhoffs, Leona Dold, Marijo Parčina, Arne Schneidewind, Maria Willis, Thomas F. E. Barth, Tobias J. Weismüller, Taotao Zhou, Philipp Lutz, Julian A. Luetkens, Peter Gerlach, Steffen Manekeller, Jörg C. Kalff, Tim O. Vilz, Christian P. Strassburg, Glen Kristiansen. Alveolar Echinococcosis in a Patient with Presumed Autoimmune Hepatitis and Primary Sclerosing Cholangitis: An Unexpected Finding after Liver TransplantationPathogens 2023; 12(1): 73 doi: 10.3390/pathogens12010073
14
Aalam Sohal, Kris V. Kowdley. Complete Biochemical Remission With Oral Vancomycin in a Patient With Primary Sclerosing Cholangitis and High Serum Immunoglobulin G4 LevelsACG Case Reports Journal 2024; 11(1): e01256 doi: 10.14309/crj.0000000000001256
15
Michele S. Barnhill, Channa Jayasekera. Secondary Sclerosing CholangiopathiesCurrent Hepatology Reports 2024; 23(1): 145 doi: 10.1007/s11901-024-00646-7
16
Kathleen Möller, Barbara Braden, EmmaL Culver, Christian Jenssen, EhsanSafai Zadeh, Amjad Alhyari, Christian Görg, André Ignee, Michael Hocke, Yi Dong, Siyu Sun, Siegbert Faiss, ChristophF Dietrich. Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis – A review of cholangiographic and ultrasound imagingEndoscopic Ultrasound 2023; 12(2): 181 doi: 10.4103/EUS-D-22-00208
17
M. Álvarez García, J.C. Álvarez Torices, M.J. Díez Liébana, M.R. de la Fuente Olmos. Manifestaciones toracoabdominales de las enfermedades relacionadas con la inmunoglobulina G4Radiología 2023; 65(2): 165 doi: 10.1016/j.rx.2022.06.002
18
Serena Babboni, Pier Giuseppe Vacca, Ludovica Simonini, Daniele Pezzati, Caterina Martinelli, Francesco Frongillo, Giuseppe Bianco, Emanuele Marciano, Giuseppina Basta, Davide Ghinolfi, Serena Del Turco. Cholangiocyte Organoids: The New Frontier in Regenerative Medicine for the Study and Treatment of CholangiopathiesJournal of Clinical Medicine 2024; 13(6): 1804 doi: 10.3390/jcm13061804
19
Henry H. Nguyen, Marvin J. Fritzler, Mark G. Swain. A Review on Biomarkers for the Evaluation of Autoimmune Cholestatic Liver Diseases and Their Overlap SyndromesFrontiers in Molecular Medicine 2022; 2 doi: 10.3389/fmmed.2022.914505
20
Taotao Zhou, Henrike Lenzen, Leona Dold, Bennet Bündgens, Heiner Wedemeyer, Michael P. Manns, Maria A. Gonzalez‐Carmona, Christian P. Strassburg, Tobias J. Weismüller. Primary sclerosing cholangitis with moderately elevated serum‐IgG4 – characterization and outcome of a distinct variant phenotypeLiver International 2021; 41(12): 2924 doi: 10.1111/liv.15028
21
A. K. Guseva, A. V. Okhlobystin. Clinical Features, Differential Diagnosis and Treatment of IgG<sub>4</sub>-Related Sclerosing CholangitisThe Russian Archives of Internal Medicine 2024; 14(2): 96 doi: 10.20514/2226-6704-2024-14-2-96-107
22
Daniel E. Radford‐Smith, Emmanuel A. Selvaraj, Rory Peters, Michael Orrell, Jonathan Bolon, Daniel C. Anthony, Michael Pavlides, Kate Lynch, Alessandra Geremia, Adam Bailey, Emma L. Culver, Fay Probert. A novel serum metabolomic panel distinguishes IgG4‐related sclerosing cholangitis from primary sclerosing cholangitisLiver International 2022; 42(6): 1344 doi: 10.1111/liv.15192
23
O. V. Khlynova, P. V. Kosareva, D. S. Fadeev, L. V. Sivakova, E. I. Samodelkin. The role of B-lymphocytes and plasma cells in the pathogenesis of inflammatory bowel diseasesExperimental and Clinical Gastroenterology 2023; (6): 39 doi: 10.31146/1682-8658-ecg-214-6-39-46
24
Zhijie Lv, Li Wu, Yan Lu, Shan Liu, Qiushuang Li. Bibliometric analysis of IgG4-related disease research from 2003 to 2022 based on Web of Science Core Collection DatabasesClinical Rheumatology 2023; 42(1): 15 doi: 10.1007/s10067-022-06377-8
25
Sylvia Drazilova, Eduard Veseliny, Patricia Denisa Lenartova, Dagmar Drazilova, Jakub Gazda, Ivica Grgurevic, Martin Janicko, Peter Jarcuska, Yu-Chen Fan. IgG4-Related Sclerosing Cholangitis: Rarely Diagnosed, but not a Rare DiseaseCanadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/1959832
26
Miroslav Vujasinovic, Karouk Said, Christina Villard, Jennifer Carlsson, Christopher Poli, Patrick Maisonneuve, J.-Matthias Löhr. The Role of Immunoglobulin G4 in Outcomes of Primary Sclerosing CholangitisJournal of Clinical Medicine 2023; 13(1): 79 doi: 10.3390/jcm13010079
27
Aalam Sohal, Kris V. Kowdley. Novel preclinical developments of the primary sclerosing cholangitis treatment landscapeExpert Opinion on Investigational Drugs 2024; 33(4): 335 doi: 10.1080/13543784.2024.2330738